Formulation and in vitro evalution of diacerein loaded niosomes

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 6, Issue SUPPL. 2, 2014, Pages 515-521

  Zaki, Randa M ^a   Ali, Adel A ^a   El Menshawe, Shahira F ^a   Bary, Ahmed Abdel ^b  

^a Beni Suef University   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

Cholesterol; Diacerein; Entrapment efficiency; In vitro release; Niosomes

Indexed keywords

CHOLESTEROL; COSURFACTANT; DIACEREIN; NIOSOME; NONIONIC SURFACTANT;

ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG RELEASE; DRUG SCREENING; DRUG SOLUBILITY; ENCAPSULATION; IN VITRO STUDY; INFRARED SPECTROSCOPY; PARTICLE SIZE; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

EID: 84896480362     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Gannu PK, Pogaku R. Non ionic surfactant vesicular systems for effective drug delivery an overview. 2011, Acta Pharmaceutica Sinica B.; 1(4):208-19.
2. Latif N, Garg AK, Chauhan M. Ultradeformable vesicles: concept and execution. 2009, Pharm Times, 41:11-14.
3. Sankar V, Ruckmani K, Jailan S, Ganesan KS, Sharavanan S. Niosome drug delivery systems: advances and medical applications an overview. 2009, Pharmacol Online; 2: 926-932.
4. Uchegbu IF, Vyas SP. Non ionic surfactant based vesicles (niosomes) in drug delivery. 1998, Int J Pharm.; 172: 33-70.
5. Manosroi A, Chutoprapat R, Abe M, Manosroi J. Characteristics of niosomes prepared by supercritical carbon dioxide (sc CO2) fluid. 2008, Int J Pharm. Mar 20; 352(1-2):248-55
6. Pham TT, Jaafar-Maalej C, Charcosset C, Fessi H. Liposome and niosome preparation using a membrane contactor for scale-up. 2012, Colloids Surf B: Biointerfaces. Jun 1; 94:15-21.
7. Uchegbu IF, Vyas SP. Non ionic surfactant based vesicles (niosomes) in drug delivery. 1998, Int J Pharm.; 172: 33-70.
8. Muzzalupo R, Nicoletta FP, Trombino S, Cassano R, Iemma F, Picci N. A new crown ether as vesicular carrier for 5-fluoruracil: synthesis, characterization and drug delivery evaluation. 2007, Colloids Surf B: Biointerfaces. Aug 1; 58(2):197-202
9. Marianecci C, Paolino D, Celia C, Fresta M, Carafa M, Alhaique F. Non ionic surfactant vesicles in pulmonary glucocorticoid delivery: characterization and interaction with human lung fibroblasts. 2010, J Control Release., Oct 1;147(1):127-35
10. Mehta SK, Jindal N, Kaur G. Quantitative investigation, stability and in vitro release studies of anti-TB drugs in Triton niosomes. 2011, Colloids Surf B: Biointerfaces. Oct 1; 87 (1):173-179.
11. Akhter S, Kushwaha S, Warsi MH et al. Development and evaluation of nanosized niosomal dispersion for oral delivery of Ganciclovir. 2012, Drug Dev Ind Pharm. Jan; 38 (1): 84-92.
12. Bragagni M, Mennini N, Ghelardini C, Mura P. Development and characterization of niosomal formulations of doxorubicin aimed at brain targeting. 2012, J Pharm Pharm Sci.; 15(1):184-96.
13. Marianecci C, Rinaldi F, Mastriota M, Pieretti S, Trapasso E, Paolino D, Carafa M. Anti-inflammatory activity of novel ammonium glycyrrhizinate/niosomes delivery system: human and murine models. 2012, J Control Release. Nov 28;164(1):17-25.
14. Cable C., An examination of the effects of surface modifications on the physicochemical and biological properties of non-ionic surfactant vesicles. PhD thesis. Glasgow: University of Strathclyde; 1989
15. Biju S. S., Talegaonkar S., Mishara P. R., Khar R. K. Vesicular systems: an overview. 2009, Ind J of Pharm Sci,; vol. 71, 421-427.
16. Fang JY, Hong CT, Chiu WT, Wang YY. Effect of liposomes and niosomes on skin permeation of enoxacin. 2001, Int J Pharm; 219:61-72.
17. Fang JY, Yu SY, Wu PC, Huang YB, Tsai YH. In vitro skin permeation of estradiol from various proniosome formulations. 2001, Int J Pharm; 215:91-9.
18. Balakrishnan P, Shanmugam S, Lee WS, Lee WM, Kim JO, Oh DH. Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery. 2009, Int J Pharm; 377:1-8.
19. Solanki AB, Parikh JR, Parikh RH. Evaluation of different compositions of niosomes to optimize aceclofenac transdermal delivery. 2010, Asian J Pharm Sci; 5:87-95.
20. Florence AT. New drug delivery systems. Chem Ind December 1993; 20:1000-4.
21. Junyaprasert VB, Teeranachaideekul V, Supaperm T. Effect of charged and non ionic membrane additives on physicochemical properties and stability of niosomes. 2008, AAPS PharmSciTech., 9(3):851-859.
22. Vyas SP, Khar RK. Targeted and Control Drug Delivery. 1st ed., Chap. 6, CBS Publishers and Distributors, New Delhi, 2002, pp. 249-276.
23. 2O niosome system. 2007, Colloid Surf A Physicochem Eng Aspects; 293: 255-61.
24. Oneil M, Heckelman PE, Koch CB. In: The Merck Index. An Encyclopedia of Chemicals: Drugs and Biologicals, 14th ed., Merck, Whitehouse Station, NJ, USA, 2006; p. 503.
25. Toegel S, Huang W, Piana C, Unger FM, Wirth M, Goldring MB, Gabor F, Viernstein H. Selection of reliable reference genes for qPCR studies on chondroprotective action. 2007, BMC Mol Biol.; 8:13.
26. Tamura T, Shirai T, Kosaka N, Ohmori K, Takafumi N. Pharmacological studies of diacerein in animal models of inflammation, arthritis and bone resorption. 2002, Eur J Pharmacol.; 448: 81-87.
27. Tamura T, Ohmori K. An active metabolite of diacerein, suppresses the interleukin-1α-induced proteoglycan degradation in cultured rabbit articular chondrocytes. 2001, Jpn J Pharmacol.; 85:101-104.
28. Diacerein Product Description. Xian Guanyu Bio- Tech Co. Ltd. Available at http://www.bikudo.com/product_search/details/44285/diacerein.html (accessed on August 10, 2009).
29. Diacerein Capsules. Ostomod. Available at http://www.cipladoc.com/therapeutic/pdfcipla/ostomod.pdf (accessed on August 10, 2009).
30. Moore JW, Flanner H. Mathematical comparison of dissolution profiles. 1996, Pharm Technol.; 20: 64-74.
31. Silverstein RM, Bassler GC, Morrill TC. Spectroscopic Identification of Organic Compounds. 5th ed., John Wiley & Sons Inc., NY, USA, 1991.
32. Yogeshwar GB, Vandan BP. Microemulsion based vaginal gel of clomitrazole: formulation, in vitro evaluation and stability studies. 2009, AAPS PharmSciTech, 10, 476-481.
33. Hunter CA, Dolan TF, Coombs GH, Baillie AJ. Vesicular systems (niosome and liposomes) for delivery of sodium stibo gluconate in experimental murine visceral leishmaniasis. 1988, J Pharm Pharmacol;40:161-5.
34. Nasseri B. Effect of cholesterol and temperature on the elastic properties of niosomal membranes. Int J Pharm 2005; 300:95-101.
35. Maia CS, Mehnert W, Schafer-Korting M. Solid lipid nanoparticles as drug carriers for topical glucocorticoids. 2000, Int J Pharm., 196, 165-167.
36. Lippacher A, Muller RH, Madder K. Preparation of semisolid drug carriers for topical application based on solid lipid nanoparticles. 2001, Int J Pharm., 214, 9-12.
37. Lippacher A, Muller RH, Madder K. Semisolid SLN dispersions for topical application: influence of formulation and production parameters on viscoelastic properties. 2002, Eur J Pharm Biopharm, 53, 155-160.
38. Wei L, Meiling H, Wenshuang L et al. Investigation of the carbopol gel of solid lipid nanoparticles for the transdermal iontophoretic delivery of triamcinolone acetonide acetate. 2008, Int J Pharm., 364, 135-141.
39. Guinedi AS, Mortada ND, Mansour S, Hathout RM. Preparation and evaluation of reverse phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide. 2005, Int J Pharm., Dec 8; 306 (1-2):71-82.